Real MR blood pool imaging agent
Characterization of a novel gadolinium-based high molecular weight polymer as an intravascular MR contrast agent
In this study we report on a novel gadolinium-based polymer that acts as an intravascular MR contrast agent (blood pool contrast agent) having a high contrast efficiency as well as optimal biocompatibility and clearance properties. The agent enables higher resolution through a higher efficacy and a pronounced steady state period for a wide acquisition timeframe in magnetic resonance angiography (MRA). Additionally, the novel agent can be of use in studies of renal structure and function.
To download the application sheet (PDF) please click on the image!